FREMONT, Calif., Feb. 23, 2021 /PRNewswire/ -- The premium market intelligence report published by BIS Research on the title Global Single-Cell Multi-Omics Market highlights that the market is projected to reach $3.18 billion by 2025. The study also highlights that the market is set to witness a CAGR of 21.16% during the period between 2020 and 2025. The growth is aided by factors including increasing utilization of single-cell RNA sequencing for various cancer research.
The single-cell multi-omics approach enables integrating different molecules and analyzing different types of molecules from a same cell. This helps in accessing multi-faceted information and insights on the characteristics of molecular layers of several individual cells. The information derived is further beneficial in diagnosing and modifying the drugs being developed. Through the advances in single-cell analysis assays, information on the genotypic and phenotypic traits could be revealed along with the regulatory mechanism of the cell at a single-cell resolution.
Market numbers on micro-segments that are influencing the market
More than 300 products present in the market
Market share analysis for more than 15 companies
End-user preference data for over 20 end users
Detailed global and regional market share analysis including the scrutiny of more than 15 countries
Study of data of more than 30 companies
Who Should Buy This Report?
Manufacturers of sequencing instruments, kits, assays, and consumables
Manufacturers of imaging instruments, kits, assays, and consumables
Companies involved in drug manufacturing and diagnostics development
Companies in the services market such as contract research organization
Companies involved in developing bioinformatics tools for single-cell data analysis, visualization, sharing, and storage
To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include end user and market share analysis, types of products offered, type of omics, sample type, application, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.
The premium market intelligence by BIS Research additionally throws a spotlight on the opportunities existing in the market, including the high scope for adoption of genomic-based medicine in emerging nations, increased use of single-cell technology solutions for the development of therapeutics drugs and comprehensive treatment plan, and requirement for the development of advanced solutions based on single-cell technology, among others.
The end user and pricing analysis of the global market includes data analysis on the satisfaction level of different instruments (by brand), pricing analysis of preferred instruments, accessories & components, and consumables. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as consumables and instruments. The consumables are further categorized into kits and reagents.
To emphasize the dominance of the consumable segment over the instruments segment under the product category of single-cell multi-omics market in 2020 and 2025, Nitish Kumar Singh, Principal Analyst – BIS Research, states, "The reason for market growth can be attributed to the large-scale research and development and recent advancement in sequencing technologies aiding researchers to unravel translational and transcription events at a single-cell resolution, attracting many molecular diagnostics and pharma giants to expand their portfolios in this sector ."
Key insights are drawn from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The key players profiled in the report include NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, 10x Genomics, Inc., Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation. The report also contains company profiles of five emerging players, namely Proteona, BioTuring Inc., Scipio Biosciences SAS, Parse Biosciences, Inc., and Shilps Sciences.
The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.
BIS Research, a premium market intelligence company offers in-depth insights and consulting to Fortune 500 companies. We are established and known for tracking the growth of deep technologies across key industry verticals and the subsequent challenges and opportunities associated with deep tech across markets, applications and products.
With more than 500 clients, over 7000 plus primary interviews and approximately 200 reports published in a year BIS Research has set an interesting growth trajectory for itself. We provide market estimations, emerging high-growth applications, technology analysis, highly segmented granular country-level market data, and other important market parameters that come in handy for our clients during strategic decision-making.
We publish a wide gamut of syndicated market studies across industry verticals. In addition, bespoke market studies is another area where BIS Research excels at along with consulting services.
BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, MRD testing, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in precision medicine on its Insight Monk platform for the past two years successfully.
Bhavya Banga Email: firstname.lastname@example.org BIS Research Inc. 39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538-1686